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ABSTRACT 
Prior studies have shown that sleep disturbance is closely associated with cognitive 
decline in older adults. However, one cannot use standard regression models to verify the causal 
relationship between sleep disorder and cognitive dysfunction. In this study, by combining 
propensity score weighting and honest causal tree technique, we balanced baseline characteristics 
between individuals with and without a certain type of sleep disorder, effectively partitioned 
older adults into groups based on the baseline conditions, and estimated heterogeneity in sleep 
disturbance impacts on cognitive function. We analyzed the data collected from the first nine 
waves of an ongoing community-based cohort study and the propensity score weighting causal 
tree model showed the causal effect of sleep disturbance on cognitive decline in various types of 
sleep disorder and cognitive domains. Sleep disorders caused faster decline in the memory and 
visuospatial domains. In addition, these causal relationship showed different effects among 
people with different sociodemigraphic or baseline health conditions, including age, gender, self-
reported general health, systolic blood pressure (BP), diastolic BP, exercise, subjective memory 
complaint, and other baseline cognitive domain scores. Our findings advance the knowledge in 
cognitive dysfunction among the elderly and allow us to validate sleep disturbance as a 
therapeutic target for treating cognitive decline in older adults. 
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PUBLIC HEALTH SIGNIFICANCE: Sleep deprivation and cognitive impairment are 
common among older adults yet the causal relationship between sleep disturbance and cognitive 
decline remains controversial. Causal tree method employed in this study directly clarified the 
causal effect of sleep deprivation on cognitive degeneration, thus improves our understanding of 
the underlying mechanisms for cognitive impairment among the elderly also helps clinicians 
with diagnosis and prognosis.  In addition, the modifiable moderators examined in this study can 
help clinicians and public health practitioners find appropriate prevention and treatments for 
sleep disturbances. 
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1.0  INTRODUCTION 
Sleep deprivation is a well-recognized health issue among the elderly. Approximately half of the 
older adults suffer from a sleep disorder with estimated 25% show symptoms of insomnia 1. 
Insomnia is characterized by reduced sleep time, shorter sleep duration, and worsened sleep 
quality. Sleep disturbances commonly observed in older people include difficulty falling asleep, 
difficulty staying asleep, early morning awakening, excessive daytime sleepiness, excessive 
daytime napping, and sleep apnea.  Life habits (including exercise, use of tobacco, and alcohol), 
sleep habits, genetic, physiological, and psychological factors may cause insomnia in the elderly.   
A large body of literature have shown that sleep insufficiency and disturbance are closely 
associated with cognitive impairment or dementia 2. Evidence from cross-sectional studies and 
prospective studies in older adults supports the association of poor sleep quality with worse 
cognitive performance in attention function, visuospatial skills, and memory 3-10. Several 
prospective studies have revealed that people having excessive daytime sleepiness are at an 
increased risk of global cognitive decline 11, 12 and dementia 13. Moreover, retrospective studies, 
and prospective studies have also found the association of insomnia 14, 15 and sleep-disordered 
breathing 16-21, with reduced cognitive function. However, some cross-sectional studies and 
prospective studies have not confirmed this association 5, 16, 22-25. 
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These inconsistent findings might be due partly to the variability in measurement of sleep 
quantity and quality, and the measurement of cognitive function, partly to heterogeneity in age 
grouping, duration of follow-up, and methods of analysis. 
Regression models are widely used to study the linkage between sleep disturbance and 
cognition decline, however, such application of the models is questionable and the relationship it 
was intended to establish is weak, because the regression models target on the average effect of 
exposure (e.g. sleep disturbance) across the whole sample subjects and ignore heterogeneity in 
sample characteristic. With the development in machine learning methods, causal tree model 26 
was proposed to use observational data in estimating the effect of an exposure in each of the 
subgroups with similar effects. Causal tree method could effectively partition subjects into 
subgroups with similar exposure effect based on the given baseline covariates. Therefore, this 
method can be used to analyze heterogeneous exposure effects based on a set of baseline subject 
characteristics. 
In this study, we assessed whether sleep disturbance in older adults increases the risk of 
cognitive decline during a 9-year follow-up period. Causal tree method was used to effectively 
partition older adults into groups and estimate average sleep-disturbance effects for different 
subgroups, i.e., older adults in the same subgroup having similar sleep-disturbance effects. In 
addition, propensity score weighting derived from generalized boosted models (GBMs) was 
incorporated into the causal tree model to reduce the differences of baseline variables between 
groups. In this study, we used the propensity score weighting causal tree model to examine the 
causal relationship between sleep disturbance and cognitive decline in older adults and to 
identify subgroups with similar causal effects based on the baseline conditions. We also 
investigate whether any of the causal relationship was moderated by the known risk factors of 
3 
cognitive decline including age, sex, general health condition, blood pressures, exercise, 
subjective memory complaint, and baseline cognitive domain scores. 
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2.0  METHODS 
2.1 STUDY POPULATION 
We used data collected from the Monongahela-Youghiogheny Healthy Aging Team (MYHAT) 
study which was a community-based cohort study investigating risk and protective factors on 
cognitive function among the elderly. MYHAT participants were aged 65 or older registered 
voters randomly selected and recruited from the Monongahela-Youghiogheny area of the 
Allegheny County of Southwestern Pennsylvania 27. The inclusion criteria are older individuals 
who were not residing in a long-term care institution at the date of recruitment and the exclusion 
criteria include: previously severe impairment in vision and/or hearing, decisional incapacity, 
and severe health condition. Participants are followed annually to monitor health condition and 
behavior change and to take a set of neuropsychological cognitive examinations. Details of the 
MYHAT study have been previously described and published 27. The MYHAT study was 
approved by the University of Pittsburgh Institutional Review. 
The MYHAT study enrolled 1,982 individuals, of whom we excluded 375 individuals 
who do not have 2 or more cognitive domain test scores during the 9-year follow up; 675 
individuals do not have data on disruptive sleep questions; 7 individuals do not have data on the 
rest 6 types of sleep quality questions; and 121 individuals do not have complete information on 
the demographic or baseline health-related covariates. Our study dataset does not include 
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disruptive sleep variable that has too many missing data, and our final analytic dataset includes 
804 participants (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Older adults (65 years old or older) enrolled in the 
MYHAT study 
(n=1,982) 
Without 2 or more cognitive 
domain test scores during 
the follow up, n=375 
Subjects responded questions of sleep disorders 
(n=1,607) 
Missing data on the 
disruptive sleep question, 
n=675 
Subjects responded the rest 6 questions of sleep disorders 
(n=932) 
Missing data on these 6 
types of sleep quality 
questions, n=7 
Subjects assessed baseline health-related covariates 
(n=925) 
Missing data on the 
sociodemographic or 
baseline health-related 
covariates, n=121 
Subjects involved in current study 
(n=804) 
Figure 1 Flowchart of subjects included in the current study 
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2.2 PRIMARY EXPOSURE VARIABLE 
MYHAT Participants were administered six questions related to the quality of sleep: (1) Do you 
take longer than half an hour to fall sleep (labeled as Difficulty falling asleep subsequently)?, (2) 
Do you wake up during the night(including to go to the bathroom) and find that it takes you more 
than half an hour to go back to sleep (labeled as Difficulty staying asleep subsequently)?, (3) Do 
you wake up earlier than you want to and find that you can’t go back to sleep (labeled as Waking 
up earlier than desired subsequently)?, (4) Do you ever fall asleep while actively doing 
something during the day (labeled as Excessive daytime sleepiness subsequently)?, (5) Do you 
doze off in most of the days during a week (labeled as Excessive daytime napping 
subsequently)?, and (6) Since our last visit, have you been told that you have sleep apnea 
(labeled as Sleep apnea subsequently)? The response categories for Questions 1-4 listed above 
included 0=never/rarely, 1=sometimes, 2=usually, or 3=never sleep/awake all night. The 
response categories for Questions 5-6 included 0=no, or 1=yes. Although all questions were 
administered at the baseline and annual follow-up, our primary exposure variable only used 
baseline sleeping patterns and converted each question into a binary response: 0=no/never or 
1=other. For participants who did not answer a particular question, the variable was coded as 
missing.    
2.3 PRIMARY OUTCOME VARIABLES 
Cognitive functions are measured annually via five cognitive domains z-scores which include 
attention/processing speed, executive functions, memory, language, and visuospatial skills. 
7 
Detailed descriptions of the tests related to these 5 domains can be found in previous study 27. 
The primary outcome variable is the longitudinal cognitive change, which was computed by the 
estimated slope of cognitive domain scores over the 9-year study period from a linear mixed 
effects model with random intercept and random slope of time.  
2.4 COVARIATES 
Covariates of interest in this study included variables measured at the baseline, which included 
age (categorized as 65-74, 75-84, and 85+ years old), sex (male or female), education 
(categorized as less than, equal to, and greater than high school education), self-reported general 
health (categorized as poor/fair, good, and very good), baseline cognitive domain z-scores 
(included attention, executive, language, memory, and visuospatial domains), systolic blood 
pressure (BP), diastolic BP, smoking status (categorized as never smoker or ever smoker), 
alcohol consumption (categorized as never drinker or ever drinker), having history of 
cerebrovascular diseases (no/yes), having history of cardiovascular diseases (no/yes), exercise 
(categorized as never or ever), total number of prescription medication use (categorized as <3 or 
≥3), Instrumental Activities of Daily Living (IADL) score (categorized as 0 or >0), subjective 
memory complaints (categorized as 0 or >0), modified CES-D depression score (categorized as 
<3 or ≥3), and history of hypertension (categorized as never or ever).  
Cerebrovascular diseases included stroke and TIA (mini-stroke). Both stroke and TIA 
were categorized as never or ever. Cerebrovascular disease was categorized as never (if never 
had a stroke or a TIA) and ever (if ever had a stroke or a TIA). Cardiovascular diseases included 
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heart attack, congestive heart failure, irregular heartbeat, and cardiac arrest. If ever had any of 
these conditions, the variable was coded as 1, otherwise was coded as 0. 
2.5 STATISTICAL ANALYSES 
2.5.1 Descriptive statistics 
We performed descriptive statistical analysis using Stata 14 (StataCorp, College Station, TX) to 
(1) analyze prevalence of the six sleep disturbance patterns (Table 1); (2) analyze the relationship 
between sleep disturbance and other baseline covariates (Table 2); and (3) examine the reliability 
of randomly splitting participants into the training and estimation sets in the honest causal tree 
analysis that will be described in Section 3.3.1 (Table 4).  
Continuous variables and categorical variables were summarized as mean±standard 
deviation (SD) and number of participants with percentage, respectively.   We used chi-square 
(for categorical variables), t-test, or Kruskal-Wallis test (for continuous variables) to assess the 
difference between groups. The significance level for all analyses was set at P <0.05. 
2.5.2 Propensity score method 
To remove selection bias associated with nonrandomized or observational studies, we estimated 
the causal effect of sleep disturbance on cognitive decline by incorporating propensity score 
weights in the main analysis.  
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Propensity score for an individual 𝑖𝑖, denoted as 𝑒𝑒(𝑋𝑋𝑖𝑖) or 𝑃𝑃(𝑇𝑇𝑖𝑖|𝑋𝑋𝑖𝑖), is a conditional 
probability of being exposed given his/her baseline characteristics, where 𝑇𝑇𝑖𝑖 is the exposure 
status (𝑇𝑇 = 1 for exposed, 𝑇𝑇 = 0 for nonexpsoed) and 𝑋𝑋𝑖𝑖 is a vector of observed baseline 
covariates. In our study, the exposure group included individuals having a sleep problem and the 
nonexposure group included individuals without the sleep problem. Applying propensity score 
weighting in the main analysis model will result in a more unbiased estimate of the exposure 
effect because the pre-exposure variables were much similar (or balanced) between the exposure 
and the nonexposure groups 28. Note that using propensity score weighting method to estimate 
the causal exposure effect replies on three key assumptions: consistency (i.e., an individual's 
potential outcomes under his/her observed exposure history is precisely her observed outcomes), 
exchangeability (i.e., no unmeasured confounders), and positivity (i.e., no individuals of one 
pattern of pre-exposure covariates are all exposed or all nonexposed). Although none of these 
assumptions can be verified using the observed data, we checked whether individuals in any set 
of baseline covariate values all had sleep disturbance or none had sleep disturbance (i.e., check 
for positivity).  
Traditional approach of propensity score estimation is to fit a logistic regression model of 
exposure status on the observed baseline covariates. Recently researchers proposed the use of 
machine learning methods and proved that these methods reduce bias and the mean-squared error 
more than the traditional logistic regression method does. Among the proposed machine learning 
methods, generalized boosted model (GBM) is the most frequently used in estimating the 
propensity scores29.  
GBM is a nonparametric, automated, data-adaptive algorithm combining classification 
and regression tree (CART) with boosting, which can be used to estimate nonlinear and 
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interactive effects between the exposure status and the observed pre-exposure baseline covariates 
30 using a smoother fit. The final model consists of several regression trees by starting with a 
simple regression tree and iteratively adding another tree. At each iteration the new tree is chosen 
to be added if it provides the best fit to the residuals of the model resulted from the previous 
iteration. At the last iteration, all included trees are used to obtain an overall piecewise constant 
function. 30  
By applying the GBM-based propensity score weighting method, one can reduce the 
differences in the baseline covariates between the exposed and the nonexposed groups. We used 
absolute standardized mean difference (ASMD) to measure the degree of balancing between the 
two groups after weighting. ASMD or effect sizes d is defined as the absolute weighted group 
mean difference divided by the unweighted standard deviation in the exposed group. We ran the 
GBM algorithm using the R package twang with the maximum iteration number (n.tree) set 
to 10,000 in order to minimize the ASMD. Because our goal is to identify heterogeneity of the 
effects of sleep disturbance, that is, we are interested in estimating the effect of sleep disturbance 
in different subgroups, especially for those who are more likely to have sleep problems, we 
employed the average treatment effect across the treated groups (ATT) instead of average 
treatment effect (ATE) in the propensity score analysis.  
We used the R package twang to implement the propensity score estimation via GBM. 
To optimize the likelihood function at each iteration in GBM, we allowed four-way interactions 
(interaction.depth = 4 in twang) between all covariates. We performed the metric ASMD 
(es.mean in twang) to assess the balance and summarize across covariates. Shrinkage was set 
to be 0.01 to yield smooth fits. To evaluate the success of propensity score weighting, we 
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examined whether the exposed and the nonexposed groups have similar distributions for all 
covariates. 
2.5.3 Causal tree and honest causal tree 
The causal tree method 26 was derived from the traditional CART approach for investigating 
heterogeneity in exposure effects, which recursively partition subjects into subgroups according 
to the observed characteristics. A causal tree model focuses on estimating conditional average 
exposure effects instead of the prediction outcomes. To avoid overfitting, the honest causal tree 
method was proposed. The honest causal tree is a two-step procedure that randomly divides 
subjects into the training subsample and the estimation subsample, where the training subsample 
is used to split the tree and the estimation subsample is used to estimate the exposure effects. 
We applied the honest causal tree method with GBM-based propensity score weighting to 
estimate the causal effect of each type of sleep disturbance on cognitive changes measured by the 
slopes of change for the 5 cognitive domain scores. 
Let 𝑁𝑁1𝑗𝑗 and 𝑁𝑁0𝑗𝑗 be the numbers of individuals in the exposure group (𝑇𝑇 = 1) and 
nonexposure group (𝑇𝑇 = 0) for the 𝑗𝑗th leaf of the tree 1. Note: 𝑁𝑁1𝑗𝑗 + 𝑁𝑁0𝑗𝑗 = 𝑁𝑁𝑗𝑗, sample size for 
the 𝑗𝑗th leaf.  Using the propensity score weighting method, we estimated the outcome difference 
between the exposure and the nonexposure groups by: 
𝑂𝑂��𝑋𝑋𝑗𝑗� = 𝑌𝑌�1𝑗𝑗 − 𝑌𝑌�0𝑗𝑗 = �∑  𝑌𝑌1𝑗𝑗𝑒𝑒(𝑋𝑋𝑗𝑗)T=1 � − �∑  𝑒𝑒(𝑋𝑋𝑗𝑗)1−𝑒𝑒(𝑋𝑋𝑗𝑗)T=0 �−1 �∑   𝑌𝑌01−𝑒𝑒(𝑋𝑋𝑗𝑗)T=0 �,  
where 𝑌𝑌1𝑗𝑗 and 𝑌𝑌0𝑗𝑗 indicate outcomes for subjects who exposed and who did not expose, 
respectively; and 𝑒𝑒�𝑋𝑋𝑗𝑗� denotes the propensity of being exposed given the observed 
characteristics 𝑋𝑋𝑗𝑗,for leaf 𝑗𝑗. 
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Let 𝑆𝑆1𝑗𝑗2  and 𝑆𝑆0𝑗𝑗2  denote the within-leaf variance of outcome 𝑌𝑌𝑗𝑗 among exposed and the 
nonexposed individuals, respectively. Therefore, variance of 𝑂𝑂��𝑋𝑋𝑗𝑗� can be estimated by 
𝑉𝑉𝑉𝑉𝑉𝑉�𝑂𝑂��𝑋𝑋𝑗𝑗�� = 𝑆𝑆1𝑗𝑗2𝑁𝑁1𝑗𝑗 + 𝑆𝑆0𝑗𝑗2𝑁𝑁0𝑗𝑗. 
Honest causal tree, which is different from the CART, splits at a node with minimum 
expected mean squared error EMSE(Str, Sest) over the training and the estimation sets. That is, for 
a node, we minimize 
EMSE(Str, Sest) = −� 1
𝑁𝑁𝑡𝑡𝑡𝑡
�∑𝑂𝑂�(𝑋𝑋)2 + ( 1
𝑁𝑁𝑡𝑡𝑡𝑡
 + 1
𝑁𝑁𝑒𝑒𝑒𝑒𝑡𝑡
)∑Var[𝑂𝑂�(𝑋𝑋)], 
where Str  and  Sest denote the training samples and the estimation samples, respectively; and Ntr 
and Nest denote the sample size of the training and the estimation samples, respectively.  
We utilized the R package CausalTree to analyze heterogeneity effects of sleep 
disturbance on the decline of cognitive function. We randomly split the observations in half to 
form a training set and an estimation data set. The minimum leaf size was set to having at least 
thirty exposure and thirty nonexposure subjects. When pruning the tree, we picked the optimum 
complexity parameter as the minimum cross-validation (CV), error(minerr) and set CV error 
≤ miner +1 SD.  
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3.0  RESULTS 
3.1 DESCRIPTIVE 
Nearly one third of the older adults reported to have sleep disturbance at baseline (Table 1). For 
each type of the sleep disturbance, 40.30% had difficulty falling asleep, 42.41% had difficulty 
staying asleep, 27.49% had the problem of waking up earlier than desired, 30.35% had the 
problem of excessive or uncontrolled daytime sleepiness, 38.81% had the issue of excessive 
daytime napping, and 9.08% had self-reported sleep apnea.  
 
 
Table 1. Descriptive statistics for sleeping deprivation at baseline 
 
 
 
 
         
  
N=804 total participants 
 
Many of the baseline covariates are associated with sleep quality (Table 2). Older adults 
aged 75-84 were more likely to experience early awakenings than desired (P<0.05). Difficulty 
falling asleep (P<0.001) and excessive daytime napping (P=0.01) were more common in older 
Baseline sleeping pattern Present 
Difficult in falling asleep,n(%) 324 (40.30) 
Difficult in staying asleep,n(%) 341 (42.41) 
Earlier waking up than desired,n(%) 221 (27.49) 
Excessive daytime sleepiness,n(%) 244 (30.35) 
Excessive daytime napping,n(%) 312 (38.81) 
Sleep apnea,n(%) 73 (9.08) 
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women than in older men. Individuals with high school degree or being nonsmokers were more 
likely to suffer from having difficulty falling asleep (P<0.05). Self-reported good health was 
related to the presence of sleep disturbance, including difficulty falling asleep, difficulty staying 
asleep, waking up earlier than desired, and sleep apnea. Older adults with sleep disturbance, 
except sleep apnea, tended to have modified CES-D depression score <3 (less depressed) or have 
subjective memory complaints. Subjects without daily activity dependence (IADL score=0) 
suffered from excessive daytime napping and sleep apnea. The elderly who took more 
prescription medication (≥ 3) were more likely to have difficulty falling asleep and report sleep 
apnea.  
Health conditions could disrupt sleep in older people. The subjects having systolic BP 
tended to have difficulty falling asleep (P<0.05) and excessive daytime sleepiness (P<0.01). 
Diabetes were related to difficulty falling asleep (P<0.05), difficulty staying asleep (P<0.05), 
excessive daytime napping (P<0.01), and sleep apnea (P<0.001). Those who having hypertension 
tended to suffer from difficulty falling asleep (P<0.001), excessive daytime sleepiness (P=0.05), 
and sleep apnea (P<0.05). Excessive daytime napping was common in older adults having 
history of heart attack or congestive heart failure (P<0.05). Irregular heartbeat was related to 
difficulty falling asleep (P<0.05), difficulty staying asleep (P<0.05), and waking up earlier than 
desired (P<0.01). 
Sleep deprivation were also related to cognitive impairment in older adults. Older adults 
with excessive daytime sleepiness tended to have lower baseline cognitive scores in executive 
function (P<0.05), language (P<0.001), and memory domains (P<0.001). In addition, lower 
executive domain score was associated with difficulty falling asleep (P<0.05).  
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Table 2. Descriptive of sleeping pattern and other covariates at baseline 
  
  
Baseline 
variable  
  
Difficult in falling 
asleep 
  
  
Difficult in staying 
asleep 
  
  
Earlier waking up 
than desired 
  
  
Excessive daytime 
sleepiness 
  
  
Excessive daytime 
napping 
  
  
Sleep apnea   
  
(n=804) (n=804) (n=804) (n=804) (n=804) (n=804) 
 No Yes P value No Yes P value No Yes P 
value 
No Yes P value No Yes P value No Yes P value 
Age in 
years,n(%) 
  0.239*   0.737*   0.025
* 
  0.359*   0.158*   0.052* 
65-74 192 
(40.00) 
119 
(36.73) 
184 
(39.74) 
127 
(37.24) 
209 
(35.85) 
102 
(46.15) 
225 
(40.18) 
86 
(35.25) 
202 
(41.06) 
109 
(34.94) 
273 
(37.35) 
38 
(52.05) 
75-84 238 
(49.58) 
159 
(49.07) 
226 
(48.81) 
171 
(50.15) 
303 
(51.97) 
94 
(42.53) 
272 
(48.57) 
125 
(51.23) 
230 
(46.75) 
167 
(53.53) 
368 
(50.34) 
29 
(39.73) 
85+ 50 
(10.42) 
46 
(14.20) 
53 
(11.45) 
43 
(12.61) 
71 
(12.18) 
25 
(11.31) 
63 
(11.25) 
33 
(13.52) 
60 
(12.20) 
36 
(11.54) 
90 
(12.31) 
6 
(8.22) 
Female 
gender, 
n(%) 
292 
(60.83) 
241 
(74.38) 
<0.001
* 
296 
(63.93) 
237 
(69.50) 
0.099* 376 
(64.49) 
157 
(71.04) 
0.080
* 
381 
(68.04) 
152 
(62.30) 
0.113* 343 
(69.72) 
190 
(60.90) 
0.010* 491 
(67.17) 
42 
(57.53) 
0.097* 
Education, 
n(%) 
  0.023*   0.116*   0.439
* 
  0.366*   0.429*   0.070* 
<HS 65 
(13.54) 
40 
(12.35) 
62 
(13.39) 
43 
(12.61) 
73 
(12.52) 
32 
(14.48) 
67 
(11.96) 
38 
(15.57) 
62 
(12.60) 
43 
(13.78) 
91 
(12.45) 
14 
(19.18) 
HS 195 
(40.63) 
163 
(50.31) 
192 
(41.47) 
166 
(48.68) 
255 
(43.74) 
103 
(46.61) 
254 
(45.36) 
104 
(42.62) 
228 
(46.34) 
130 
(41.67) 
334 
(45.69) 
24 
(32.88) 
>HS 220 
(45.83) 
121 
(37.35) 
209 
(45.14) 
132 
(38.71) 
255 
(43.74) 
86 
(38.91) 
239 
(42.68) 
102 
(41.80) 
202 
(41.06) 
139 
(44.55) 
306 
(41.86) 
35 
(47.95) 
Self-reported 
geneal 
health,n(%) 
  0.014*   <0.001
* 
  0.001
* 
  0.067*   0.143*   0.033* 
Poor/Fair 61 
(12.71) 
54 
(16.67) 
54 
(11.66) 
61 
(17.89) 
68 
(11.66) 
47 
(21.27) 
70 
(12.50) 
45 
(18.44) 
61 
(12.40) 
54 
(17.31) 
98 
(13.41) 
17 
(23.29) 
Good 211 
(43.96) 
162 
(50.00) 
194 
(41.90) 
179 
(52.49) 
272 
(46.66) 
101 
(45.70) 
261 
(46.61) 
112 
(45.90) 
231 
(46.95) 
142 
(45.51) 
338 
(46.24) 
35 
(47.95) 
Very good 208 
(43.33) 
108 
(33.33) 
215 
(46.44) 
101 
(29.62) 
243 
(41.68) 
73 
(33.03) 
229 
(40.89) 
87 
(35.66) 
200 
(40.65) 
116 
(37.18) 
295 
(40.36) 
21 
(28.77) 
Ever 
smoking, 
n(%) 
255 
(53.13) 
147 
(45.37) 
0.031* 244 
(52.70) 
158 
(46.33) 
0.074* 285 
(48.89) 
117 
(52.94) 
0.304
* 
288 
(51.43) 
114 
(46.72) 
0.220* 233 
(47.36) 
169 
(54.17) 
0.060* 364 
(49.79) 
38 
(52.05) 
0.713* 
Ever drinking, 
n(%) 
416 
(86.67) 
284 
(87.65) 
0.682* 400 
(86.39) 
300 
(87.98) 
0.508* 506 
(86.79) 
194 
(87.78) 
0.709
* 
493 
(88.04) 
207 
(84.84) 
0.214* 432 
(87.80) 
268 
(85.90) 
0.432* 636 
(87.00) 
64 
(87.67) 
0.871* 
Exercise, 
n(%) 
302 
(62.92) 
209 
(64.51) 
0.646* 296 
(63.93) 
215 
(63.05) 
0.798* 367 
(62.95) 
144 
(65.16) 
0.561
* 
367 
(65.54) 
144 
(59.02) 
0.077* 305 
(61.99) 
206 
(66.03) 
0.247* 459 
(62.79) 
52 
(71.23) 
0.153* 
mCESD 
score >=3, 
n(%) 
23 
(4.79) 
59 
(18.21) 
<0.001
* 
31 
(6.70) 
51 
(14.96) 
<0.001
* 
48 
(8.23) 
34 
(15.38) 
0.003
* 
49 
(8.75) 
33 
(13.52) 
0.040* 41 
(8.33) 
41 
(13.14) 
0.028* 71 
(9.71) 
11 
(15.07) 
0.149* 
IADL 
score >0, 
n(%) 
39 
(8.13) 
30 
(9.26) 
0.573* 41 
(8.86) 
28 
(8.21) 
0.747* 52 
(8.92) 
17 
(7.69) 
0.579
* 
42 
(7.50) 
27 
(11.07) 
0.097* 29 
(5.89) 
40 
(12.82) 
0.001* 58 
(7.93) 
11 
(15.07) 
0.038* 
No of Rx 
medications 
337 
(70.21) 
249 
(76.85) 
0.038* 326 
(70.41) 
260 
(76.25) 
0.066* 416 
(71.36) 
170 
(76.92) 
0.113
* 
406 
(72.50) 
180 
(73.77) 
0.709* 348 
(70.73) 
238 
(76.28) 
0.084* 522 
(71.41) 
64 
(87.67) 
0.002* 
16 
>=3,n(%) 
Subjective 
memory 
complaint, 
n(%) 
295 
(61.46) 
222 
(68.52) 
0.040* 284 
(61.34) 
233 
(68.33) 
0.041* 358 
(61.41) 
159 
(71.95) 
0.005
* 
342 
(61.07) 
175 
(71.72) 
0.004* 296 
(60.16) 
221 
(70.83) 
0.002* 464 
(63.47) 
53 
(72.60) 
0.121* 
Health outcome history 
Systolic blood 
pressure, 
mean(SD) 
130.54
(15.05) 
133.27 
(16.08) 
0.032# 131.33 
(14.99) 
132.05 
(16.23) 
0.514# 131.59 
(15.58) 
131.78 
(15.41) 
0.844
# 
130.58 
(15.20) 
134.08 
(16.00) 
0.003# 131.45 
(14.99) 
131.94 
(16.35) 
0.800# 131.60 
(15.54) 
132.01(1
5.44) 
0.889# 
Diastolic 
blood 
pressure, 
mean(SD) 
72.37 
(8.51) 
73.43 
(8.16) 
0.088# 72.62 
(8.47) 
73.04 
(8.27) 
0.371# 72.53 
(8.64) 
73.50 
(7.64) 
0.247
# 
72.61 
(8.31) 
73.21 
(8.56) 
0.179# 72.63 
(8.52) 
73.05 
(8.17) 
0.247# 72.71 
(8.35) 
73.63 
(8.76) 
0.266# 
Stroke, 
n(%) 
15 
(3.13) 
11 
(3.40) 
0.832# 16 
(3.46) 
10 
(2.93) 
0.679# 16 
(2.74) 
10 
(4.52) 
0.203
# 
19 
(3.39) 
7 
(2.87) 
0.699# 16 
(3.25) 
10 
(3.21) 
0.971# 21 
(2.87) 
5 
(6.85) 
0.078# 
TIA,n(%) 38 
(7.92) 
39 
(12.04) 
0.051* 42 
(9.07) 
35 
(10.26) 
0.570* 58 
(9.95) 
19 
(8.60) 
0.561
* 
51 
(9.11) 
26 
(10.66) 
0.493* 46 
(9.35) 
31 
(9.94) 
0.783* 69 
(9.44) 
8 
(10.96) 
0.676* 
Diabetes, 
n(%) 
123 
(25.62) 
61 
(18.83) 
0.024* 118 
(25.49) 
66 
(19.35) 
0.041* 141 
(24.19) 
43 
(19.46) 
0.154
* 
127 
(22.68) 
57 
(23.36) 
0.832* 95 
(19.31) 
89 
(28.53) 
0.002* 155 
(21.20) 
29 
(39.73) 
<0.001* 
Hypertension
,n(%) 
314 
(65.42) 
254 
(78.40) 
<0.001
* 
315 
(68.03) 
253 
(74.19) 
0.058* 403 
(69.13) 
165 
(74.66) 
0.124
* 
384 
(68.57) 
184 
(75.41) 
0.050* 340 
(69.11) 
228 
(73.08) 
0.228* 508 
(69.49) 
60 
(82.19) 
0.023* 
Heartattack,n
(%) 
58 
(12.08) 
51 
(15.74) 
0.137* 56 
(12.10) 
53 
(15.54) 
0.158* 77 
(13.21) 
32 
(14.48) 
0.638
* 
76 
(13.57) 
33 
(13.52) 
0.986* 56 
(11.38) 
53 
(16.99) 
0.024* 97 
(13.27) 
12 
(16.44) 
0.451* 
Congestive 
heart failure, 
n(%) 
28 
(5.83) 
25 
(7.72) 
0.270* 26 
(5.62) 
27 
(7.92) 
0.215* 34 
(5.83) 
19 
(8.60) 
0.097
* 
33 
(5.89) 
20 
(8.20) 
0.150* 25 
(5.08) 
28 
(8.97) 
0.042* 44 
(6.02) 
9 
(12.33) 
0.134* 
Irregular 
heartbeat, 
n(%) 
125 
(26.04) 
108 
(33.33) 
0.037* 119 
(25.70) 
114 
(33.43) 
0.027* 153 
(26.24) 
80 
(36.20) 
0.005
* 
154 
(27.50) 
79 
(32.38) 
0.113* 130 
(26.42) 
103 
(33.01) 
0.057* 204 
(27.91) 
29 
(39.73) 
0.101* 
Cardiac 
arrest,n(%) 
8 
(1.67) 
6 
(1.85) 
0.565* 6 
(1.30) 
8 
(2.35) 
0.219* 10 
(1.72) 
4 
(1.81) 
0.368
* 
8 
(1.43) 
6 
(2.46) 
0.168* 7 
(1.42) 
7 
(2.24) 
0.268* 11 
(1.50) 
3 
(4.11) 
0.206* 
Cognitive domain score 
Attention, 
mean(SD) 
0.14 
(0.77) 
0.15  
( 0.72) 
0.464# 0.12 
(0.76) 
0.17 
 ( 0.73) 
0.231# 0.13 
(0.74) 
0.19 
(0.76) 
0.269
# 
0.17 
 ( 0.75) 
0.09 
 ( 0.75) 
0.123# 0.18 
 ( 0.74) 
0.10 
(0.75) 
0.202# 0.14 
(0.74) 
0.21 
(0.79) 
0.539# 
Executive 
,mean(SD) 
0.17 
(0.72) 
0.19 
(0.66) 
0.975# 0.15 
 ( 0.74) 
0.22 
 ( 0.64) 
0.229# 0.17 
 ( 0.70) 
0.22 
 ( 0.67) 
0.429
# 
0.21 
 ( 0.71) 
0.11 
 ( 0.66) 
0.023# 0.21 
 ( 0.68) 
0.14 
(0.71) 
0.164# 0.17 
(0.69) 
0.32 
(0.76) 
0.129# 
Language, 
mean(SD) 
0.18 
(0.71) 
0.16 
(0.69) 
0.467# 0.16 
( 0.74) 
0.19 
 ( 0.64) 
0.874# 0.16 
 ( 0.72) 
0.22 
 ( 0.66) 
0.443
# 
0.23 
 ( 0.68) 
0.04 
 ( 0.73) 
<0.001
# 
0.17 
 ( 0.71) 
0.18 
 ( 0.69) 
0.895# 0.17 
(0.70) 
0.25 
(0.73) 
0.299# 
Memory, 
mean(SD) 
0.25 
(0.67) 
0.15 
 ( 0.68) 
0.047# 0.23 
(0.69) 
0.18 
(0.66) 
0.159# 0.24 
 ( 0.70) 
0.15 
 ( 0.62) 
0.093
# 
0.27 
 ( 0.68) 
0.08 
 ( 0.66) 
<0.001
# 
0.24 
 ( 0.65) 
0.17 
 ( 0.71) 
0.139# 0.21 
(0.68) 
0.22 
(0.65) 
0.984# 
Visuospatial,
mean(SD) 
0.13 
(1.00) 
0.13 
(1.02) 
0.905# 0.13 
(1.04) 
0.13 
(0.95) 
0.866# 0.13 
(1.01) 
0.12 
(1.00) 
0.912
# 
0.18 
(1.02) 
0.03 
 (0.97) 
0.055# 0.14 
(1.00) 
0.12 
(1.02) 
0.558# 0.12 
(0.99) 
0.27 
(1.15) 
0.263# 
Age- Age at baseline; Self-reported general health-Subjective health assessment at baseline; mCESD score-Modified CES-D depression score; IADL score-Score 
on the IADL questions at baseline; No of Rx medications-Total number of prescription medications at baseline; Attention-Standardized attention domain score at 
baseline; Executive-Standardized executive function domain score at baseline; Language-Standardized language domain score at baseline; Memory-Standardized 
memory domain score at baseline; Visuospatial-Standardized visuospatial domain score at baseline.  
*-For categorical variables: p-value was calculated using Chi-square test (Fisher exact test if sample size is too small); # - For continuous variables: p-value was 
calculated using Kruskal_Wallis test; bold P represents statistically significant difference between groups. 
Table 2 Continued 
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3.2 GENERALIZED BOOSTED MODEL(GBM) PROPENSITY SCORE WEIGHTS 
3.2.1 GBM propensity score weights resulting in balanced distributions of covariates 
In this study, ASMD values greater than 0.2 were considered moderate imbalance. 
Unweighted analysis in Figure 2 and Table 3 showed substantial mean differences 
between the exposure (with sleep disturbance) and nonexposure (without sleep disturbance) 
groups, expressed by the imbalanced variables (imbalanced variables for difficulty falling asleep: 
gender, general health, mCES-D score, and hypertension; imbalanced variables for difficulty 
staying asleep: general health, and mCES-D score; imbalanced variables for waking up earlier 
than desired: general health and subjective memory complaints; imbalanced variables for 
excessive daytime sleepiness: subjective memory complaints, systolic BP, baseline language 
domain score, and baseline memory domain score; imbalanced variables for excessive daytime 
napping: IADL score, subjective memory complaints, diabetes, and heart failure; imbalanced 
variables for sleep apnea: age, general health, number of prescription medications, subjective 
memory complaints, diabetes, hypertension, and heart failure) with ASMD larger than 0.2. 
After applying propensity score weighting, as shown in Figure 2 and Table 3, differences 
in baseline covariates between the exposure and nonexposure groups diminished substantially. 
No variable had an effect size (measured by ADMD) over 0.2, indicating balance in covariates 
after applying GBM-based propensity score weights to the data.  
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For panels A-F, each dot depicts unweighted (left side, before applying propensity score weights) or weighted (right 
side, after applying propensity score weights) absolute standard mean difference (ASMD) of a particular covariate at 
baseline between the exposure (with sleep disturbance) and nonexposure (without sleep disturbance) groups. Open 
circle and closed circles indicate statistically nonsignificant (P≥0.05) and significant (P<0.05) mean difference of a 
A            Difficult in falling asleep B           Difficult in staying asleep 
 
 
C         Earlier waking up than desired D         Excessive daytime sleepiness 
  
E               Excessive daytime napping F                         Sleep apnea 
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baseline covariate between the exposure group and nonexposure groups, respectively. Corresponding variates were 
connected with lines. Absolute standard mean value for each variable is equal to absolute weighted group mean 
difference divided by the unweighted standard deviation for the exposure group and was summarized in Table 3. 
 
Figure 2. Reduced absolute standard mean difference in baseline covariates between older adults with and 
without sleep disturbance after GBM propensity score weighting 
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Table 3A. Baseline covariates characteristics and group difference before and after GBM propensity score weighting 
  Difficult in falling asleep Difficult in staying asleep 
Unweighted   Propensity Score Weighted Unweighted   Propensity Score 
Weighted 
Nonexposure Exposure   Nonexposure   Nonexposure Exposure   Nonexposure   
Covariate 
 
Mean SD Mean SD Effect 
size 
Mean SD Effect 
size 
Mean SD Mean SD Effect 
size 
Mean SD Effect 
size 
Demographics 
Age(yrs) 1.704 0.646 1.775 0.678 0.104 1.699 0.628 0.112 1.717 0.658 1.754 0.663 0.055 1.699 0.647 0.083 
Female 0.608 0.489 0.744 0.437 0.310 0.714 0.453 0.069 0.639 0.481 0.695 0.461 0.121 0.649 0.478 0.101 
Education 2.323 0.700 2.250 0.660 -1.500 2.285 0.679 -0.054 2.317 0.697 2.261 0.668 -0.085 2.303 0.665 -0.063 
Self-reported geneal health 2.306 0.684 2.167 0.688 -0.203 2.231 0.683 -0.093 2.348 0.679 2.117 0.68 -0.339 2.226 0.666 -0.160 
Ever smoking 0.531 0.500 0.454 0.499 -0.156 0.495 0.500 -0.083 0.527 0.500 0.463 0.499 -0.127 0.508 0.500 -0.090 
Ever drinking 0.867 0.340 0.877 0.329 0.030 0.860 0.347 0.050 0.864 0.343 0.880 0.326 0.049 0.878 0.328 0.006 
Exercise 0.629 0.484 0.645 0.479 0.033 0.640 0.481 0.011 0.639 0.481 0.630 0.483 -0.018 0.649 0.478 -0.039 
mCESD score >=3 0.048 0.214 0.182 0.387 0.347 0.108 0.310 0.192 0.067 0.250 0.150 0.357 0.231 0.083 0.276 0.186 
IADL score 0.081 0.274 0.093 0.290 0.039 0.094 0.293 -0.006 0.089 0.284 0.082 0.275 -0.023 0.093 0.291 -0.039 
No of Rx medications 0.702 0.458 0.769 0.422 0.157 0.732 0.443 0.087 0.704 0.457 0.762 0.426 0.137 0.736 0.441 0.062 
Subjective memory 
complaint 
0.615 0.487 0.685 0.465 0.152 0.655 0.476 0.066 0.613 0.487 0.683 0.466 0.15 0.647 0.478 0.078 
Health outcome history 
Cerebro 0.106 0.308 0.145 0.353 0.110 0.122 0.327 0.066 0.119 0.324 0.126 0.332 0.022 0.117 0.322 0.027 
Diabetes 0.256 0.437 0.188 0.392 -0.174 0.201 0.401 -0.033 0.255 0.436 0.194 0.396 -0.155 0.217 0.413 -0.060 
Hypertension 0.654 0.476 0.784 0.412 0.315 0.753 0.432 0.075 0.680 0.467 0.742 0.438 0.141 0.710 0.454 0.072 
Cardiac 0.356 0.479 0.441 0.497 0.171 0.370 0.483 0.143 0.350 0.477 0.446 0.498 0.193 0.371 0.484 0.150 
Systolic blood pressure 130.540 15.050 133.269 16.080 0.170 132.158 14.180 0.069 131.335 14.986 132.053 16.233 0.044 131.867 14.899 0.011 
Diastolic blood pressure 72.369 8.512 73.426 8.158 0.130 73.380 7.963 0.006 72.616 8.471 73.038 8.267 0.051 73.003 8.358 0.004 
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Cognitive domain score 
Attention 0.140 0.769 0.152 0.716 0.017 0.179 0.715 -0.038 0.124 0.762 0.172 0.729 0.065 0.179 0.712 -0.009 
Executive 0.175 0.721 0.192 0.657 0.026 0.193 0.640 -0.002 0.154 0.737 0.219 0.635 0.103 0.205 0.639 0.022 
Language 0.183 0.714 0.159 0.687 -0.036 0.180 0.647 -0.032 0.162 0.744 0.188 0.645 0.041 0.200 0.642 -0.018 
Memory 0.253 0.674 0.153 0.678 -0.147 0.222 0.652 -0.102 0.235 0.687 0.182 0.662 -0.080 0.230 0.651 -0.073 
Visuospatial 0.131 0.996 0.133 1.020 0.002 0.134 0.971 -0.001 0.131 1.043 0.133 0.985 0.002 0.176 0.973 -0.046 
 
Table 4B. Baseline covariates characteristics and group difference before and after GBM propensity score weighting 
  Earlier waking than desired Excessive daytime sleepiness 
Unweighted   Propensity Score Weighted Unweighted   Propensity Score 
Weighted 
Nonexposure Exposure   Nonexposure   Nonexposure Exposure   Nonexposure   
Covariate 
 
Mean SD Mean SD Effect 
size 
Mean SD Effect 
size 
Mean SD Mean SD Effect 
size 
Mean SD Effect 
size 
Demographics 
Age(yrs) 1.763 0.652 1.652 0.675 -0.166 1.663 0.616 -0.017 1.711 0.657 1.783 0.665 0.108 1.731 0.640 0.078 
Female 0.645 0.479 0.710 0.455 0.144 0.695 0.461 0.033 0.680 0.467 0.623 0.486 -0.118 0.682 0.466 -0.122 
Education 2.312 0.683 2.244 0.690 -0.098 2.262 0.660 -0.026 2.307 0.673 2.262 0.712 -0.063 2.266 0.684 -0.005 
Self-reported geneal health 2.300 0.666 2.118 0.729 -0.250 2.229 0.671 -0.152 2.284 0.674 2.172 0.717 -0.156 2.208 0.687 -0.050 
Ever smoking 0.489 0.500 0.529 0.500 0.081 0.514 0.500 0.031 0.514 0.500 0.467 0.500 -0.094 0.494 0.500 -0.053 
Ever drinking 0.868 0.339 0.878 0.328 0.030 0.879 0.327 -0.003 0.880 0.325 0.848 0.359 -0.089 0.861 0.346 -0.036 
Exercise 0.630 0.483 0.652 0.478 0.046 0.652 0.477 -0.001 0.655 0.476 0.590 0.493 -0.132 0.624 0.485 -0.068 
mCESD score >=3 0.082 0.275 0.154 0.362 0.198 0.083 0.276 0.195 0.088 0.283 0.135 0.343 0.139 0.107 0.309 0.083 
IADL score 0.089 0.285 0.077 0.267 -0.046 0.081 0.273 -0.015 0.075 0.264 0.111 0.314 0.113 0.088 0.283 0.073 
Table 3A Continued 
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No of Rx medications 0.714 0.452 0.769 0.422 0.132 0.763 0.426 0.015 0.725 0.447 0.738 0.441 0.029 0.748 0.434 -0.024 
Subjective memory 
complaint 
0.614 0.487 0.719 0.450 0.234 0.658 0.475 0.136 0.611 0.488 0.717 0.451 0.236 0.662 0.474 0.123 
Health outcome history 
Cerebro 0.122 0.327 0.122 0.328 0.001 0.114 0.318 0.025 0.121 0.327 0.123 0.329 0.005 0.122 0.328 0.002 
Diabetes 0.242 0.429 0.195 0.397 -0.119 0.199 0.399 -0.011 0.227 0.419 0.234 0.424 0.016 0.228 0.420 0.012 
Hypertension 0.691 0.462 0.747 0.436 0.127 0.744 0.437 0.006 0.686 0.465 0.754 0.432 0.158 0.754 0.431 -0.001 
Cardiac 0.372 0.484 0.439 0.497 0.134 0.383 0.487 0.112 0.382 0.486 0.410 0.493 0.056 0.380 0.486 0.060 
Systolic blood pressure 131.587 15.578 131.778 15.407 0.012 132.104 13.713 -0.021 130.577 15.200 134.078 16.001 0.219 133.304 14.388 0.048 
Diastolic blood pressure 72.527 8.638 73.502 7.639 0.128 73.645 7.727 -0.019 72.612 8.306 73.213 8.557 0.070 73.525 7.977 -0.036 
Cognitive domain score 
Attention 0.126 0.742 0.194 0.763 0.090 0.144 0.712 0.066 0.168 0.747 0.090 0.747 -0.105 0.128 0.670 -0.051 
Executive 0.166 0.704 0.222 0.675 0.082 0.180 0.621 0.062 0.213 0.710 0.110 0.657 -0.157 0.169 0.621 -0.091 
Language 0.157 0.721 0.217 0.655 0.093 0.202 0.610 0.024 0.230 0.684 0.042 0.730 -0.258 0.142 0.620 -0.138 
Memory 0.236 0.697 0.150 0.616 -0.139 0.197 0.603 -0.075 0.272 0.675 0.077 0.661 -0.294 0.179 0.598 -0.154 
Visuospatial 0.135 1.009 0.125 0.997 -0.010 0.076 0.932 0.049 0.176 1.016 0.032 0.974 -0.148 0.107 0.909 -0.077 
 
Table 5C. Baseline covariates characteristics and group difference before and after GBM propensity score weighting 
  Excessive daytime napping Sleep apnea 
Unweighted   Propensity Score Weighted Unweighted   Propensity Score 
Weighted 
Nonexposure Exposure   Nonexposure   Nonexposure Exposure   Nonexposure   
Covariate 
 
Mean SD Mean SD Effect 
size 
Mean SD Effect 
size 
Mean SD Mean SD Effect 
size 
Mean SD Effect 
size 
Demographics 
Table 3B Continued 
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Age(yrs) 1.711 0.671 1.766 0.671 0.085 1.744 0.656 0.034 1.750 0.659 1.562 0.645 -0.291 1.695 0.654 -0.207 
Female 0.697 0.460 0.609 0.489 -0.180 0.666 0.472 -0.117 0.672 0.470 0.575 0.498 -0.194 0.647 0.478 -0.144 
Education 2.285 0.676 2.308 0.700 0.033 2.278 0.681 0.042 2.294 0.676 2.288 0.772 -0.008 2.289 0.695 -0.002 
Self-reported geneal health 2.283 0.672 2.199 0.712 -0.118 2.247 0.677 -0.068 2.269 0.682 2.055 0.724 -0.296 2.196 0.684 -0.196 
Ever smoking 0.474 0.500 0.542 0.499 0.136 0.496 0.500 0.091 0.498 0.500 0.521 0.503 0.045 0.520 0.500 0.001 
Ever drinking 0.878 0.328 0.859 0.349 -0.055 0.875 0.331 -0.047 0.870 0.336 0.877 0.331 0.020 0.870 0.337 0.022 
Exercise 0.620 0.486 0.660 0.474 0.085 0.622 0.485 0.081 0.628 0.484 0.712 0.456 0.185 0.684 0.465 0.061 
mCESD score >=3 0.085 0.277 0.131 0.338 0.142 0.087 0.282 0.131 0.097 0.296 0.151 0.360 0.149 0.118 0.323 0.090 
IADL score 0.059 0.236 0.128 0.335 0.207 0.090 0.286 0.114 0.079 0.270 0.151 0.360 0.198 0.084 0.277 0.186 
No of Rx medications 0.707 0.455 0.763 0.426 0.130 0.737 0.441 0.061 0.714 0.452 0.877 0.331 0.491 0.801 0.399 0.228 
Subjective memory 
complaint 
0.602 0.490 0.708 0.455 0.234 0.667 0.472 0.091 0.635 0.482 0.726 0.449 0.203 0.653 0.476 0.162 
Health outcome history 
Cerebro 0.120 0.325 0.125 0.331 0.015 0.126 0.332 -0.002 0.118 0.322 0.164 0.373 0.125 0.126 0.332 0.103 
Diabetes 0.193 0.395 0.285 0.452 0.204 0.222 0.416 0.139 0.212 0.409 0.397 0.493 0.376 0.297 0.457 0.203 
Hypertension 0.691 0.463 0.731 0.444 0.089 0.720 0.449 0.024 0.695 0.461 0.822 0.385 0.330 0.767 0.423 0.142 
Cardiac 0.350 0.477 0.455 0.499 0.212 0.403 0.491 0.105 0.378 0.485 0.521 0.503 0.284 0.417 0.493 0.205 
Systolic blood pressure 131.447 14.988 131.942 16.347 0.030 132.694 15.114 -0.046 131.602 15.540 132.014 15.436 0.027 131.924 15.298 0.006 
Diastolic blood pressure 72.634 8.520 73.048 8.168 0.051 73.497 8.188 -0.055 72.711 8.345 73.630 8.758 0.105 73.279 8.356 0.040 
Cognitive domain score 
Attention 0.175 0.743 0.096 0.754 -0.104 0.110 0.732 -0.018 0.138 0.743 0.206 0.793 0.085 0.176 0.787 0.038 
Executive 0.211 0.683 0.136 0.714 -0.105 0.157 0.648 -0.030 0.168 0.688 0.317 0.763 0.196 0.245 0.706 0.095 
Language 0.170 0.713 0.178 0.689 0.011 0.163 0.692 0.022 0.165 0.701 0.254 0.726 0.122 0.207 0.709 0.064 
Memory 0.237 0.654 0.175 0.710 -0.087 0.192 0.692 -0.025 0.212 0.679 0.222 0.654 0.017 0.206 0.630 0.025 
Visuospatial 0.137 0.997 0.124 1.019 -0.013 0.111 1.008 0.013 0.118 0.989 0.274 1.147 0.136 0.175 1.032 0.087 
Comparing covariates pretreatment differences between groups before and after GBM propensity score weighting. 
Exposure-subjects with sleep problem; Nonexposure-subjects without sleep problem; effect sizes= absolute group mean difference divided by the standard 
deviation for the exposed group. 
 
Table 3C Continued 
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3.2.2 GBM propensity score weights caused covariates follow uniform distribution 
P-Values from a random experiment have a uniform distribution (45-degree line) due to balanced 
covariates between groups. 
Solid diamonds in Figure 3 indicated the p-values for the t-tests of equal group 
differences in covariates before weighting. Severe deviation of the p-value below the diagonal 
suggested statistically significant differences between groups in covariates. After applying the 
GBM-based propensity score weighting (open squares in Figure 3), the p-values for the t-tests of 
equal group differences in the covariate means increased suggesting improved balance in 
covariates.  
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Q-Q plot comparing the group differences of covariates to the uniform distribution before and after GBM propensity 
score weights. Solid diamonds depict p-values for t-test of group differences on covariates before weighting. Open 
squares depict p-values after weighting. Blue 45-degree line depicts uniform distribution of random experiment. 
Each dot depicts a particular covariate at baseline. 
 
Figure 3. Improved randomness after GBM propensity score weights
A            Difficult in falling asleep B           Difficult in staying asleep 
  
C             Earlier waking up than desired D           Excessive daytime sleepiness 
  
E               Excessive daytime napping F                         Sleep apnea 
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3.3 CAUSAL IMPACT OF SLEEP DEPRIVATION ON COGNITIVE DECLINE 
Using the honest causal tree method, we examined the causal effect of sleep deprivation 
(difficulty falling asleep, difficulty staying asleep, waking up earlier than desired, excessive 
daytime sleepiness, excessive daytime napping, and sleep apnea) on cognitive decline (including 
attention, executive, memory, language, and visuospatial domains), after adjusting for baseline 
demographic, health-related conditions, and baseline standardized cognitive domain scores. The 
results suggested that having difficulty falling asleep, difficulty staying asleep, excessive 
daytime sleepiness, and excessive daytime napping led to faster cognitive decline in the memory 
and visuospatial domains. These causal relationship also showed different effects among people 
with different sociodemigraphic or baseline health conditions, including age, gender, self-
reported general health, systolic BP, diastolic BP, exercise, and baseline cognitive domain 
scores.   
 
3.3.1 Randomly splitting samples into training set and estimation set 
Before building a causal tree model, observations were randomly divided into approximately 
50% for the training and 50% for the estimation sets. The training set was used to build a causal 
tree model, and the estimation set was used to evaluate the accuracy of the model built.  
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As shown in Table 4, no statistically significant difference in baseline covariates (except 
age and subjective memory complaint) between the training and the estimation samples, 
suggesting the similarity of baseline characteristics between these two sub-samples. 
 
Table 6. Comparing baseline covariates between training set and estimation set 
 
 
Baseline variable 
Testing set Training set   
(n=389) (n=415) P value 
Age in years, n(%)   0.013 
65-74 146(37.53) 165(39.76)  
75-84 183(47.04) 214(51.57)  
85+ 60(15.42) 36(8.67)  
Female gender, n(%) 265(68.12) 268(64.58) 0.288 
Education, n(%)   0.123 
    <HS 56(14.40) 49(11.81)  
    HS 182(46.79) 176(42.41)  
    >HS 151(38.82) 190(45.78)  
General self-reported health, n(%)   0.521 
Poor/Fair 61(15.68) 54(13.01)  
    Good 180(46.27) 193(46.51)  
    Very good 148(38.05) 168(40.48)  
    Ever smoking, n(%) 195(50.13) 207(49.88) 0.944 
Ever drinking, n(%) 339(87.15) 361(86.99) 0.947 
Exercise, n(%) 244(62.72) 267(64.34) 0.635 
mCES-D score >=3, n(%) 44(11.31) 38(9.16) 0.313 
IADL score >0, n(%) 39(10.03) 30(7.23) 0.157 
No of Rx medications >=3, n(%) 275(70.69) 311(74.94) 0.176 
Subjective memory complaint >0, 
n(%) 
267(68.64) 250(60.24) 0.013 
Health outcome history 
Systolic blood pressure, mean(SD) 131.13(15.16) 132.12(15.85) 0.367 
Diastolic blood pressure, mean(SD) 72.40(8.43) 73.16(8.33) 0.200 
Stroke, n(%) 17(4.37) 9(2.17) 0.109 
TIA, n(%) 43(11.05) 34(8.19) 0.168 
Diabetes, n(%) 78(20.05) 106(25.54) 0.064 
Hypertension, n(%) 270(69.41) 298(71.81) 0.455 
Heart attack, n(%) 55(14.14) 54(13.01) 0.641 
Congestive heart failure, n(%) 26(6.68) 27(6.51) 0.583 
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Table 4 Continued 
Irregular heartbeat, n(%) 102(26.22) 131(31.57) 0.151 
Cardiacrrest, n(%) 6(1.54) 8(1.93) 0.690 
Sleep disturbance 
    Difficult in falling sleep, n(%) 163(41.90) 161(38.80) 0.369 
    Difficult in staying sleep, n(%) 161(41.39) 180(43.37) 0.569 
    Earlier waking up than desired, 
n(%) 
102(26.22) 119(28.67) 0.436 
    Excessive daytime sleepiness, n(%) 118(30.33) 126(30.36) 0.993 
    Excessive daytime napping, n(%) 146(37.53) 166(40.00) 0.473 
    Sleep apnea, n(%) 33(8.48) 40(9.64) 0.569 
Cognitive domain score 
    Attention, mean(SD) 0.11(0.72) 0.18(0.77) 0.160 
    Executive function, mean(SD) 0.14(0.73) 0.22(0.66) 0.115 
    Language, mean(SD) 0.14(0.74) 0.20(0.66) 0.269 
    Memory, mean(SD) 0.17(0.73) 0.25(0.63) 0.087 
    Visuospatial, mean(SD) 0.08(1.02) 0.18(0.99) 0.152 
Age- Age at baseline; Self-reported general health-Subjective Health Assessment at baseline; mCES-D score-
Modified CES-D depression score; IADL score-Score on the IADL questions at baseline; No of Rx medications-
Total number of prescription medications at baseline; Difficult in falling asleep-take longer than a half an hour to 
fall asleep; Difficult in staying asleep-wake up during the night and find that it takes more than a half hour to go 
back to sleep; Earlier waking up than desired -wake up earlier than you want to and find that you can’t go back to 
sleep; Excessive daytime sleepiness- fall asleep while actively doing something during the day; Excessive 
daytime napping -doze off or take a nap most days of the week; Attention-Standardized attention domain score at 
baseline; Executive-Standardized executive function domain score at baseline; Language-Standardized language 
domain score at baseline; Memory-Standardized memory domain score at baseline; Visuo-spatial-Standardized 
visuospatial domain score at baseline.  
p-value was calculated using Chi-square test (categorical variables) or t-test or Kruskal-Wallis test (continuous 
variables); bold P represents statistically significant difference between groups; N=804 total participants. 
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3.3.2 Causal effect of difficulty falling asleep on cognitive decline 
Figure 4 showed heterogeneous effect of difficulty falling asleep on cognitive performance that 
having difficulty falling asleep led to cognitive deficits in executive, language, memory and 
visuospatial functions during the 9-year follow up. For each node, a positive number indicates a 
faster decline among those who had difficulty falling asleep than that among those who did not 
have difficulty falling asleep. A negative number indicates a slower decline among those who 
had difficulty falling asleep. 
Figure 4A showed that having difficulty falling asleep caused greater executive function 
decline. Comparing the slopes of 9-yaer executive function domain scores between those who 
had and did not have difficulty falling asleep, executive function declined faster among 
individuals who had higher diastolic BP (≥80). 
Figure 4B showed that having difficulty falling asleep caused language cognitive decline 
in older adults over time. Comparing the slopes of language function domain scores between 
those who had and did not have difficulty falling asleep, faster language decay was associated 
with those who had higher visuospatial domain score (≥ -0.47) and reported poor or fair general 
health conditions. 
Figure 4C showed that having difficulty falling asleep led to a worsening memory in 
elderly over time. Comparing the slopes of memory function domain scores between those who 
had and did not have difficulty falling asleep, rapid memory loss was associated with those who 
had lower baseline executive score (<0.69) and no subjective memory complaint, or associated 
with elderly having subjective memory complaint and baseline attention score ≥0.043.  
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Figure 4D showed that having difficulty falling asleep caused visuospatial cognitive 
decline. Comparing the slopes of visuospatial function domain scores between those who had 
and did not have difficulty falling asleep, visuospatial function declines faster among individuals 
who either had baseline memory domain score <0.25 and executive function score <0.14 or had 
baseline memory domain score ≥0.25  but were younger (65-74 years old). 
 
 
A            Executive domain slope 
 
B           Language domain slope 
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C             Memory domain slope 
 
D           Visuo-spatial domain slope 
 
Causal tree algorithm to examine the heterogeneity of difficulty falling asleep on cognitive domain scores decline. 
Within each node, the top number represents the mean difference in the slopes of cognitive domain scores between 
those who had and did not have difficult in falling asleep, and the bottom number shows the percentage of total 
affected participants. Positive number (dark blue) indicates faster slope changes of cognitive function domain scores 
among those who had difficulty falling asleep than that among those without sleep disorder. Negative numbers (light 
blue) means slower slope changes of cognitive function domain scores among those who had difficulty falling 
asleep than slope changes among those without sleep disorder.  
Abbreviations: diastole-Diastolic blood pressure; systol-Systolic blood pressure; visuospa- Standardized visuo-
spatial domain scores at baseline; language- Standardized language domain scores at baseline; exectiv- Standardized 
executive domain scores at baseline; attentio- Standardized attention domain scores at baseline; memory- 
Standardized memory domain scores at baseline; health-Self-reported general health condition at baseline; smc1-
Score on the subjective memory complaint scale at baseline; agec-Age at baseline in years. 
 
Figure 4. Causal effect of falling asleep on cognitive domain slope change 
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3.3.3 Causal effect of difficulty staying asleep on cognitive decline 
Figure 5 showed heterogenous effect of difficulty staying asleep on cognitive performance. 
Having difficult in staying asleep resulted in cognitive decline in attention domain, executive 
domain, memory domain, and visuo-spatial domain in older adults during the 9-year follow up. 
This causal relationship was moderated by baseline cognitive domain scores, baseline systolic 
BP, and gender. 
Figure 5A showed that having difficulty staying asleep caused attention cognitive 
decline. Comparing the slopes of attention function domain scores between those who had and 
did not have difficulty staying asleep, rapid attention decline  was associated with those who had 
lower baseline memory score (<0.0022) and systolic BP<129. 
Figure 5B showed that having difficult in staying asleep impaired executive performance 
over time. Comparing the slopes of executive function domain scores between those who had 
and did not have difficulty staying asleep, rapid executive impairment was associated with those 
who had higher baseline language domain scores (≥-0.2).  
As shown in Figure 5C, comparing the slopes of memory function domain scores 
between those who had and did not have difficulty staying asleep, faster memory loss was 
associated with those who had higher baseline executive domain score ≥0.79. 
Figure 5D showed that having difficulty staying asleep impaired visuospatial function.  
Comparing the slopes of visuospatial function domain scores between those who had and did not 
have difficulty staying asleep, faster visuospatial degeneration was associated with those who 
had higher baseline memory score (≥0.68). 
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A            Attention domain slope  
 
B           Executive domain slope  
 
C             Memory domain slope 
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D           Visuo-spatial domain slope 
 
Causal tree algorithm to examine the heterogeneity of difficulty staying asleep on cognitive domain slope decline. 
Within each node, the top number represents the mean difference in the slope of cognitive domain scores between 
those who had and did not have difficult in staying asleep, and the bottom shows the percentage of total affected 
participants. Positive number indicates faster slope changes of cognitive function domain scores among those had 
difficulty falling asleep than slope changes among those without sleep disorder. Negative numbers mean slower 
slope changes of cognitive function domain scores among those had difficulty falling asleep than slope changes 
among those without sleep disorder. 
Abbreviations: systol-Systolic blood pressure; language- Standardized language domain scores at baseline; exectiv- 
Standardized executive domain scores at baseline; attentio- Standardized attention domain scores at baseline; 
memory- Standardized memory domain scores at baseline; cardiac-Cardiovascular disease at baseline, including 
heart attack, congestive heart failure, irregular heartbeat, atrial fibrillation, heart racing, palpitations, cardiac 
arrhythmia, and cardiac arrest; sex-Gender at baseline. 
 
Figure 5. Causal effect of difficulty staying asleep on cognitive domain slope change 
 
3.3.4 Causal effect of excessive daytime sleepiness on cognitive decline 
Figure 6 showed the heterogeneous effects of excessive daytime sleepiness on cognitive 
performance. Having excessive daytime sleepiness caused cognitive decline in attention, 
language, memory, and visuo-spatial in older adults during the 9-year follow-up. This causal 
relationship was moderated by baseline characteristics, including cognitive domain scores, 
diastolic BP, self-reported general health condition, and exercise. 
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Figure 6A suggested that having excessive daytime sleepiness impaired attention function 
in older adults over time. This causal relationship was moderated by baseline memory domain 
scores, baseline diastolic BP, self-reported general health condition, and baseline attention 
domain scores. 
As shown in Figure 6A, having excessive daytime sleepiness induced attention cognitive 
decline in older adults over time. Comparing the slopes of attention function domain scores 
between those who had and did not have excessive daytime sleepiness, steeper attention decline 
was associated with individuals who had lower baseline memory domain scores (<-0.17), or 
those who had higher memory domain scores (≥-0.17) but lower diastolic BP (<70), or those 
who had higher baseline memory score (≥-0.17), higher diastolic BP ≥70, higher attention scores 
(≥ 0.16), and good general health condition. 
Figure 6B showed that having excessive daytime sleepiness resulted in language deficit 
in older adults. Comparing the slopes of language function domain scores between those who 
had and did not have excessive daytime sleepiness, rapid language decay was associated with 
those who had less exercise. 
Figure 6C showed that having excessive daytime sleepiness resulted in memory loss. 
Comparing the slopes of memory function domain scores between those who had and did not 
have excessive daytime sleepiness, faster memory loss was associated with older adults who had 
lower baseline memory domain score (<-0.17). 
Figure 6D showed that having excessive daytime sleepiness damaged visuospatial 
function in older adults. Comparing the slopes of visuospatial function domain scores between 
those who had and did not have excessive daytime sleepiness, faster visuospatial decline was 
associated with those who had higher baseline memory score (≥0.67). 
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A            Attention domain slope  
 
B           Language domain slope  
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C             Memory domain slope 
 
D           Visuo-spatial domain slope 
 
 
Causal tree algorithm to examine the heterogeneity of excessive daytime sleepiness on cognitive domain slope 
decline. Within each node, the top number represents the mean difference in the slope of cognitive domain scores 
between those who had and did not have excessive daytime sleepiness, and the bottom shows the percentage of total 
affected participants. Positive number indicates faster slope changes of cognitive function domain scores among 
those who had excessive daytime sleepiness than slope changes among those without sleep disorder. Negative 
numbers mean slower slope changes of cognitive function domain scores among those had excessive daytime 
sleepiness than slope changes among those without sleep disorder.  
Abbreviations: diastole-Diastolic blood pressure; visuospa- Standardized visuospatial domain scores at baseline; 
attentio- Standardized attention domain scores at baseline; memory- Standardized memory domain scores at 
baseline; health-Self-reported general health condition at baseline; exercise-Exercise at baseline. 
 
Figure 6. Causal effect of excessive daytime sleepiness on cognitive domain slope change
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3.3.5 Causal effect of excessive daytime napping on cognitive decline 
Figure 7 showed heterogeneous effect of excessive daytime napping on cognitive function. 
Having excessive daytime napping caused cognitive decline in language, memory and visuo-
spatial in older people during the 9-year follow-up. The cognitive decline rate was moderated by 
age, baseline systolic BP, self-reported general health condition, baseline executive domain 
scores, baseline visuo-spatial domain scores, baseline language domain scores, and gender. 
Figure 7A showed that having excessive daytime napping led to language degeneration. 
Comparing the slopes of language function domain scores between those who had and did not 
have excessive daytime napping, faster language decay was associated with those who were 65-
74 years old or were greater than 75 years old with baseline systolic BP <131. 
Figure 7B showed that having excessive daytime napping resulted in memory loss in 
older adults over time. Comparing the slopes of memory function domain scores between those 
who had and did not have excessive daytime napping, rapid memory loss was associated with 
those who reported poor/fair health condition, or those who had reported good health condition 
and had higher baseline executive score (≥0.42), or those who reported good health condition 
and had lower executive score (<0.42) and lower visuospatial scores (<0.057). 
Figure 7C showed that having excessive daytime napping resulted in visuospatial decline 
in older people with age. Comparing the slopes of visuospatial function domain scores between 
those who had and did not have excessive daytime napping, faster visuospatial degeneration was 
associated with women who had higher baseline language domain scores (≥0.23). 
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A            Language domain slope  
 
B           Memory domain slope  
 
C             Visuo-spatial domain slope 
 
40 
Causal tree algorithm to examine the heterogeneity of excessive daytime napping on cognitive domain slope decline. 
Within each node, the top number represents the mean difference in the slope of cognitive domain scores between 
those who had and did not have excessive daytime napping, and the bottom shows the percentage of total affected 
participants. Positive number indicates faster slope changes of cognitive function domain scores among those who 
had excessive daytime napping than slope changes among those without sleep disorder. Negative numbers mean 
slower slope changes of cognitive function domain scores among those had excessive daytime napping than slope 
changes among those without sleep disorder.  
Abbreviations: systol-Systolic blood pressure; visuospa- Standardized visuospatial domain scores at baseline; 
language- Standardized language domain scores at baseline; exectiv- Standardized executive domain scores at 
baseline; health-Self-reported general health condition at baseline; agec-Age at baseline in years; sex-Gender at 
baseline. 
 
Figure 7. Causal effect of excessive daytime napping on cognitive domain slope change 
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4.0  DISCUSSION 
Aging is accompanied with cognitive dysfunction to some degree, which interferes with older 
adults’ life and functioning 31, 32. Older people having cognitive impairment often self-reported 
sleep disturbance. Although the relationship between sleep deprivation and cognitive impairment 
in the elderly has been explored for decades, the association is conflicting. The inconsistent 
findings might due to the fact that traditional regression models, which focus on the average 
exposure effect across the whole sample, fail to detect the variation in this effect among the 
study individuals. By using the novel causal tree model 26, we were able to examine the causal 
relationship between sleep disturbance and cognitive impairment in subgroups according to their 
characteristics. In addition, the modifiable moderators examined in this study (e.g., age, gender, 
education, self-reported genera health condition, systolic BP, diastolic BP, smoking, alcohol 
consumption, cerebrovascular disease, cardiac disease, exercise, total number of prescription 
medications, IADL score, subjective memory complaint scale score, modified CES-D score, 
hypertension, and baseline cognitive score) can help clinicians and public health practitioners 
find appropriate prevention and treatments for sleep disturbances. 
The following statements and Table 5 are summary of the most important findings of our 
analysis. 
1. There are heterogeneous effects of sleep disorders on various cognitive function domain 
scores in older adults. 
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2. Having difficulty falling asleep caused faster cognitive declines in all domains except 
attention. The rate of decline was associated with baseline demographics, health conditions, 
and cognitive domain scores of the subjects. Our analyses showed that the causal relationship 
of difficulty falling asleep and faster cognitive decline exists in several group of subjects with 
such associations: faster executive function decline was associated with those who had higher 
diastolic BP ; faster language decay was associated with  those who had higher baseline 
visuospatial domain scores (≥-0.47) and  reported fair or bad general health condition; rapid 
memory loss was associated with those who had lower baseline executive function domain 
scores (<0.69) and no subjective memory complains, OR associated with those who had 
lower baseline executive function domain scores (<0.69) and subjective memory complains 
but had higher baseline attention domain scores (≥0.043); faster visuospatial decline was 
associated with those who either had lower baseline memory domain scores (<0.25) and 
lower executive function domain scores (<0.14) or had higher baseline memory domain 
scores (≥0.25) but were younger (65-74 years old). 
3. Having difficulty staying asleep caused faster cognitive decline in all domains except 
language. Our analyses showed that the causal relationship exists in several group of subjects 
with such associations:  rapid attention decline was associated with those who had lower 
baseline memory domain scores (<0.0022), and lower systolic BP (<129); rapid executive 
impairment was associated with those who had higher baseline language domain scores (≥ -
0.2); faster memory loss was associated with those who had higher baseline executive 
domain scores; and faster visuospatial degeneration was associated with those who had 
higher baseline memory domain scores (≥0.68). 
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4. Having excessive daytime sleepiness caused faster cognitive decline in all domains except 
executive function. This causal relationship exists among those had lower baseline memory 
domain scores (<-0.17), or those who had higher memory domain score (≥-0.17) but lower 
diastolic BP (<70), or those who had higher baseline memory (≥-0.17) and high attention (≥ 
0.16) scores, higher diastolic BP, and good general health condition (which are associated 
with faster attention decline); those who had less exercise (which is associated with rapid 
language decay); those who had lower baseline memory domain scores (<-0.17) (which is 
associated to faster memory loss); and those who had higher baseline memory domain scores 
(≥0.67) (which is associated to faster visuospatial decline).  
5. Having excessive daytime napping caused cognitive decline in all domains except attention 
and executive function domains. Our analyses showed that the causal relationship exists in 
several group of subjects with such associations: faster language decline was associated with 
those who were 65-74 years old or were greater than 75 years old with baseline systolic BP 
<131; faster memory loss was associated with those who reported either poor or fair health 
condition, or those who had reported good health condition and had higher baseline executive 
function scores (≥0.42), or those who reported good health condition and had lower 
executive function (<0.42) and lower visuospatial scores (<0.057); faster visuospatial 
degeneration was associated with women who had higher baseline language domain scores 
(≥0.23). 
 In summary, causal tree method provides another approach to explore heterogeneity 
effects of sleep disturbance on cognitive decline. Sleep disorders caused faster decline in the 
memory and visuospatial domains in older adults. These causal relationship also showed 
different effects among people with different sociodemographic or baseline health conditions. 
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Our causal tree results suggested that older adults with sleep problems can try to improve general 
health conditions, e.g., having blood pressure controlled, and having regular physical activities, 
to avoid abnormal cognitive function decline.  
However, one must be aware of the fact that unmeasured confounders could cause the 
estimated causal effect to be biased. In addition, one has to choose an optimal minimum number 
of observations in each leaf, knowing that; while a smaller number increases variance, a bigger 
number reduces heterogeneity. The optimal balance between variance and heterogeneity needs to 
be further investigated. Although we randomly split samples and balanced the group means on 
nearly all covariates in the model, selection bias and group differences in pre-exposure variables 
have not been completely removed in our study. 
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Table 7. Summary of sleep disturbance-cognitive decline causal relationship 
Cognitive domain (decline) 
affected by the sleep 
disturbance Among which subgroups 
Difficulty falling asleep  
Executive function had higher DBP 
Language had higher baseline visuospatial domain scores (≥-0.47) and 
reported fair or bad general health condition 
Memory had lower baseline executive function domain scores (<0.69) and 
no subjective memory complains; OR had lower baseline 
executive function domain scores (<0.69) and subjective memory 
complains but had higher baseline attention domain scores 
(≥0.043) 
Visuospatial either had lower baseline memory domain scores (<0.25) and 
lower executive function domain scores (<0.14) OR 65-74 years 
old who had higher baseline memory domain scores (≥0.25) 
Difficulty staying asleep  
Attention had lower baseline memory domain scores (<0.0022) and lower 
SBP (<129) 
Executive function had higher baseline language domain scores (≥ -0.2) 
Memory had higher baseline executive domain scores 
Visuospatial had higher baseline memory domain scores (≥0.68) 
Excessive daytime sleepiness  
Attention had lower baseline memory domain scores (<-0.17), OR higher 
memory domain score (≥-0.17) but lower diastolic BP (<70), OR 
higher baseline memory (≥-0.17), higher attention scores (≥ 0.16), 
higher diastolic BP (≥70), and reported good general health 
condition 
Language had less exercise 
Memory had lower baseline memory domain scores (<-0.17) 
Visuospatial had higher baseline memory domain scores (≥0.67) 
Excessive daytime napping   
Language were 65-74 years old or were greater than 75 years old with 
baseline systolic BP <131 
Memory reported either poor or fair health condition, or those who had 
reported good health condition and had higher baseline executive 
function scores (≥0.42), or those who reported good health 
condition and had lower executive function (<0.42) and lower 
visuospatial scores (<0.057) 
Visuospatial women who had higher baseline language domain scores (≥0.23) 
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APPENDIX: STATISTICAL CODES 
A.1 STATA EXAMPLE CODES 
A.1.1 Stata example codes for descriptive analysis 
/*for Table 1 to check the distributions of sleep variables*/ 
foreach var of varlist b_fallasl b_backasl b_wakearl b_sleepint b_sleepday b_dozenap 
b_apnea { 
tab `var’ 
} 
 
/*for Table 2*/ 
/*treatment=fallasl(baseline)*/ 
** categorical variables 
Foreach var of varlist agec sex educ health smoke drink stroke tia diabet hibp hrtatt 
chf irghrt mcesd1 iadl1 med1 smc1 exercise { 
tab  `var’ b_fallasl, column chi2 
} 
 
tab  cardar b_fallasl, column chi2 exact 
 
** continuous variables 
foreach var of varlist systole diastole attention executive language memory 
visuospatial { 
tabstat `var’,s(n mean SD) c(s)format(%14.2fc) by(b_fallasl) 
kwallis `var’, by(b_fallasl) 
 } 
47 
A.1.2 Stata example codes for comparing baseline covariates between the training and 
estimation subsamples 
/*for Table 4 */ 
**t-test for continuous variables  
foreach var of varlist systole diastole attention executive language memory 
visuospatial { 
ttest `var’, by(group) 
 } 
 
**chi-square test for categorical variables 
foreach var of varlist agec sex educ health b_fallasl b_backasl b_wakearl b_sleepint 
b_sleepday b_dozenap b_apnea smoke drink stroke tia diabet hibp hrtatt chf irghrt 
cardar iadl1 mcesd1 smc1 med1 exercise { 
tab `var’ group, column chi2 
 } 
A.2 R EXAMPLE CODES 
A.2.1 R example codes for randomly splitting a sample 
/* for Table 4*/ 
data1.ind<-runif(nrow(data1))<0.5 
train_set<-data1[data1.ind,] 
test_set<-data1[!data1.ind,] 
 
write.csv(train_set ,"C:/Users/GUANJOB/Desktop/biost thesis/final 
data/train_set_nonmiss.csv",row.names = T) 
write.csv(test_set ,"C:/Users/GUANJOB/Desktop/biost thesis/final 
data/test_set_nonmiss.csv",row.names = T) 
 
A.2.2 R example codes for GBM propensity score weighting 
/*for Table 3 and Figures 1-2*/ 
data1= read.csv("C:/Users/GUANJOB/Desktop/biost thesis/final data/all var without 
missing value_n= 804.csv", header=T) 
library(twang) 
set.seed(123) 
 
#1.treatment=fallasl  
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## propensity score (PS) model  
ps.data1f<-ps(b_fallasl~educ+agec+sex+health+attention+executive+memory+ 
                language+visuospatial+systol+diastol+smoke+drink+cerebro+ 
                diabet+hibp+cardiac+exercise+iadl1+mcesd1+smc1+med1, 
             data=data1, 
             n.trees=10000, 
             interaction.depth=3, 
             shrinkage=0.01, 
             perm.test.iters=0, 
             stop.methods=c("es.mean","ks.max"), 
             estimand="ATT", 
             verbose=FALSE) 
 
## Evaluate the quality of propensity score (PS) weighting  
### Checking convergence  
plot(ps.data1f) 
 
###Table 3-check balance  
data1f.balance<-bal.table(ps.data1f) #return table information on the pretreatment 
covariates before and after weighting 
data1f.balance 
 
plot(ps.data1f,plots=3) #Figure 1-standardized imbalance plot  
plot(ps.data1f,plots=4) #Figure 2-p-value plot for the t-test of group mean difference 
for each covariate 
 
###check overlap 
plot(ps.data1f,plots=2)  
summary(ps.data1f) #note ess(effective sample size) 
 
##extract PS weights from an object 
getwt_f<-get.weights(ps.data1f,stop.method = "es.mean") 
 
A.2.3 R example codes for Honest Causal Tree 
/*for Figure 3 */ 
library(rpart) 
library(rpart.plot) 
library(causalTree) 
 
##causal trees 
###1.causal tree for attention_fallasl 
tree_af<-
honest.causalTree(slope_attention~educ+agec+sex+health+attention+executive+memory+ 
                             language+visuospatial+systol+diastol+smoke+drink+cerebro+ 
                             diabet+hibp+cardiac+exercise+iadl1+mcesd1+smc1+med1, 
                           data=train_set, 
                           treatment = train_set$b_fallasl, 
                           weights=train_set$getwt_f, 
                           est_data = test_set, 
                           est_treatment = test_set$b_fallasl, 
                           est_weights=test_set$getwt_f, 
                           split.Rule = "CT", 
                           cv.option = "CT", 
                           split.Honest = T, 
                           HonestSampleSize=dim(test_set)[1], 
                           cv.Honest = T, 
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                           split.Bucket = T, 
                           split.alpha = 0.5, 
                           cv.alpha = 0.5, 
                           xval=10, 
                           minsize = 30) 
 
###plot cp 
plotcp(tree_af) 
 
## get the optimal cp value for pruning 
cptab<-tree_af$cptable 
print(cptab) 
minerr<-min(which(cptab[,4]==min(cptab[,4]))) 
minplus1se<-cptab[minerr,4]+cptab[minerr,5] 
ocp<-cptab[min(which(cptab[,4]<=minplus1se)),1] 
print(ocp) 
 
###prune the tree using the best cp 
tree_afp<-prune(tree_af,ocp) 
 
###plots 
prp(tree_afp,faclen=0,cex=0.70,extra=100,box.palette = 'auto') 
 
###2.for Figure 3.A-causal tree for executive_fallasl 
tree_ef<-
honest.causalTree(slope_executive~educ+agec+sex+health+attention+executive+memory+ 
                             language+visuospatial+systol+diastol+smoke+drink+cerebro+ 
                             diabet+hibp+cardiac+exercise+iadl1+mcesd1+smc1+med1, 
                           data=train_set, 
                           treatment = train_set$b_fallasl, 
                           weights=train_set$getwt_f, 
                           est_data = test_set, 
                           est_treatment = test_set$b_fallasl, 
                           est_weights=test_set$getwt_f, 
                           split.Rule = "CT", 
                           cv.option = "CT", 
                           split.Honest = T, 
                           HonestSampleSize=dim(test_set)[1], 
                           cv.Honest = T, 
                           split.Bucket = T, 
                           split.alpha = 0.5, 
                           cv.alpha = 0.5, 
                           xval=10, 
                           minsize = 30) 
 
###plot cp 
plotcp(tree_ef) 
 
## get the optimal cp value for pruning 
cptab<-tree_ef$cptable 
print(cptab) 
minerr<-min(which(cptab[,4]==min(cptab[,4]))) 
minplus1se<-cptab[minerr,4]+cptab[minerr,5] 
ocp<-cptab[min(which(cptab[,4]<=minplus1se)),1] 
print(ocp) 
 
###prune the tree using the best cp 
tree_efp<-prune(tree_ef,ocp) 
 
###plots 
prp(tree_efp,faclen=0,cex=0.70,extra=100,box.palette = 'auto') 
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